Literature DB >> 16238919

Lower urinary tract symptoms and erectile dysfunction: epidemiology and treatment in the aging man.

Shane Russell1, Kevin T McVary.   

Abstract

Lower urinary tract symptoms (LUTS) and erectile dysfunction (ED) are common urologic problems that are seen in the aging male population. Until recently, aging itself was considered the common link between ED and LUTS. However, recent studies have shown that the links between these two disease processes are much more complex and are possibly inter-related with a common mechanism. This newly recognized independent relationship between ED and LUTS has the potential to have a profound impact on the way we diagnose and treat these common urologic disorders.

Entities:  

Mesh：

Year:  2005        PMID： 16238919     DOI： 10.1007/s11934-005-0040-3

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   2.862


  45 in total

1.  Sildenafil influences lower urinary tract symptoms.

Authors:  K Sairam; E Kulinskaya; T A McNicholas; G B Boustead; D C Hanbury
Journal:  BJU Int       Date:  2002-12       Impact factor: 5.588

Review 2.  Erectile dysfunction and lower urinary tract symptoms secondary to BPH.

Authors:  Kevin T McVary
Journal:  Eur Urol       Date:  2005-02-22       Impact factor: 20.096

3.  Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomised controlled trial.

Authors:  Sara T Brookes; Jenny L Donovan; Tim J Peters; Paul Abrams; David E Neal
Journal:  BMJ       Date:  2002-05-04

4.  Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia.

Authors:  H A Guess; H M Arrighi; E J Metter; J L Fozard
Journal:  Prostate       Date:  1990       Impact factor: 4.104

5.  Observational multicentric trial performed with doxazosin: evaluation of sexual effects on patients with diagnosed benign prostatic hyperplasia.

Authors:  Aldo Franco De Rose; Giorgio Carmignani; Carlo Corbu; Matteo Giglio; Paolo Traverso; Angelo Naselli; Emanuele Belgrano; Costanzo Catuogno; Dario Fontana; Armando Maver; Vincenzo Mirone; Giovanni Muzzonigro; Daniele Di Trapani; Fabio Bonini
Journal:  Urol Int       Date:  2002       Impact factor: 2.089

6.  Specificity of the American Urological Association voiding symptom index: comparison of unselected and selected samples of both sexes.

Authors:  T C Chai; W D Belville; E J McGuire; L Nyquist
Journal:  J Urol       Date:  1993-11       Impact factor: 7.450

7.  Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: a population study.

Authors:  A Nicolosi; D B Glasser; E D Moreira; M Villa
Journal:  Int J Impot Res       Date:  2003-08       Impact factor: 2.896

8.  Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction.

Authors:  S A Kaplan; R B Reis; I J Kohn; R Shabsigh; A E Te
Journal:  Urology       Date:  1998-11       Impact factor: 2.649

9.  Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.

Authors:  H A Feldman; I Goldstein; D G Hatzichristou; R J Krane; J B McKinlay
Journal:  J Urol       Date:  1994-01       Impact factor: 7.450

10.  Obstructive lower urinary tract symptoms correlate with erectile dysfunction.

Authors:  Sean P Elliott; Mittul Gulati; David J Pasta; G Mark Spitalny; Christopher J Kane; Rita Yee; Tom F Lue
Journal:  Urology       Date:  2004-06       Impact factor: 2.649
View more
  5 in total

1.  Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men.

Authors:  Sean A Martin; Matthew T Haren; Villis R Marshall; Kylie Lange; Gary A Wittert
Journal:  World J Urol       Date:  2010-10-21       Impact factor: 4.226

Review 2.  Emerging gene and stem cell therapies for the treatment of erectile dysfunction.

Authors:  Ahmed Harraz; Alan W Shindel; Tom F Lue
Journal:  Nat Rev Urol       Date:  2010-02-16       Impact factor: 14.432

Review 3.  [Genetic aspects of erectile dysfunction].

Authors:  A Eisenhardt; H Sperling; H Rübben
Journal:  Urologe A       Date:  2015-05       Impact factor: 0.639

Review 4.  Guide to drug therapy for lower urinary tract symptoms in patients with benign prostatic obstruction : implications for sexual dysfunction.

Authors:  Serap Gur; Philip J Kadowitz; Wayne J G Hellstrom
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Effects of Omega-3 Fatty Acids on Erectile Dysfunction in a Rat Model of Atherosclerosis-induced Chronic Pelvic Ischemia.

Authors:  Ji Sung Shim; Dae Hee Kim; Jae Hyun Bae; Du Geon Moon
Journal:  J Korean Med Sci       Date:  2016-02-22       Impact factor: 2.153
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.